Farewell
- PMID: 33283365
- DOI: 10.1111/cea.13781
Farewell
References
REFERENCES
-
- Austin C, Gonzalez Edick M, Ferrando R, et al. A randomised, placebo-controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER). Clin Exp Allergy. 2020;50(12):1342-1351.
-
- Diver S, Russell RJ, Brightling CE. New and emerging drug treatments for severe asthma. Clin Exp Allergy. 2018;48(3):241-252.
-
- Upham JW, Jurak LM. How do biologicals and other novel therapies effect clinically used biomarkers in severe asthma? Clin Exp Allergy. 2020;50(9):994-1006.
-
- Pouessel G, Turner PJ, Worm M, et al. Food-induced fatal anaphylaxis: From epidemiological data to general prevention strategies. Clin Exp Allergy. 2018;48(12):1584-1593.
-
- Roberts G. Fatal anaphylaxis to food allergens: learning from tragedies. Clin Exp Allergy. 2018;48(11):1376-1377.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources